◀ Back to CD4
CD4 — GP5
Text-mined interactions from Literome
Yachou et al., Biochem Biophys Res Commun 1999
:
Binding of soluble recombinant HIV envelope
glycoprotein , rgp120,
induces conformational changes in the cellular membrane anchored
CD4 molecule
Basmaciogullari et al., J Virol 2002
:
Binding of the HIV-1 gp120 envelope
glycoprotein to the chemokine receptors normally
requires prior interaction with
CD4
Gorse et al., Clinical and vaccine immunology : CVI 2006
(HIV Infections) :
Mean frequencies of HIV-1 envelope
glycoprotein stimulated , activated intra-cellular IFN-gamma producing
CD4 ( + ) and CD8 ( + ) lymphocytes and of interleukin-2 producing CD4 ( + ) lymphocytes did not increase after vaccination, but cytokine producing cells were detectable in some patients
Rawat et al., Mol Membr Biol 2008
:
These engineered cells are resistant to fusion mediated
CD4 dependent HIV-1 envelope
glycoprotein
Hu et al., J Immunol 2008
(HIV Infections) :
We previously demonstrated that HIV envelope
glycoprotein ( Env ), delivered in the form of a vaccine and expressed by dendritic cells or 293T cells, could
suppress Ag-stimulated
CD4 ( + ) T cell proliferation
Azevedo-Pereira et al., Acta Med Port 2008
(HIV Infections) :
Binding of SU glycoprotein to
CD4 molecule , enables HIV to adsorb to target cell membrane and also
initiates conformational changes in SU
glycoprotein that enable it to bind to a second receptor ( coreceptor )
Kassa et al., J Virol 2009
:
Binding to the primary receptor
CD4 induces conformational changes in the human immunodeficiency virus type 1 ( HIV-1 ) gp120 envelope
glycoprotein that allow binding to the coreceptor ( CCR5 or CXCR4 ) and ultimately trigger viral membrane-cell membrane fusion mediated by the gp41 transmembrane envelope glycoprotein
Andersen et al., Scand J Immunol 1991
:
Conglutinin binds the HIV-1 envelope
glycoprotein gp 160 and
inhibits its interaction with cell membrane
CD4
Juszczak et al., J Biol Chem 1991
:
Effect of human immunodeficiency virus gp120
glycoprotein on the association of the protein tyrosine kinase p56lck with
CD4 in human T lymphocytes
Lay et al., J Biol Chem 2011
:
The binding by HIV-1 gp120 to
CD4 and a chemokine receptor
activates the membrane fusion
glycoprotein , gp41
Demaria et al., AIDS Res Hum Retroviruses 1996
:
Soluble
CD4 induces the binding of human immunodeficiency virus type 1 to cells via the V3 loop of glycoprotein 120 and specific sites in
glycoprotein 41
Martin et al., Science 1997
:
The gp120 envelope
glycoprotein from human immunodeficiency virus strain HIV-1 ( YU2 ) bound human CCR5 ( CCR5hu ) or rhesus macaque CCR5 ( CCR5rh ) only in the
presence of
CD4
Sullivan et al., J Virol 1998
:
CD4 Induced conformational changes in the human immunodeficiency virus type 1 gp120
glycoprotein : consequences for virus entry and neutralization
Wang et al., J Biol Chem 1998
:
The interaction of human immunodeficiency virus type 1 ( HIV-1 ) with
CD4 and one of a cadre of chemokine receptors
triggers conformational changes in the HIV-1 envelope ( Env )
glycoprotein that lead to membrane fusion
Sullivan et al., J Virol 1998
:
Determinants of human immunodeficiency virus type 1 envelope
glycoprotein activation by soluble
CD4 and monoclonal antibodies
Puri et al., Proc Natl Acad Sci U S A 1998
:
The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a
CD4 dependent CXCR4 utilizing HIV type 1 envelope
glycoprotein
Mavoungou et al., J Med Primatol 1998
(Monkey Diseases...) :
Our results demonstrate that the soluble viral
glycoprotein induce a specific phospholipase A2 (PLA2) activation in lymphocytes through
CD4